RCRI Calculator
The Revised Cardiac Risk Index (RCRI) estimates the probability of a major adverse cardiac event (MACE) in adults scheduled for elective noncardiac surgery. Select each risk factor that applies to your patient. The score and corresponding perioperative cardiac risk update instantly, along with a risk class and clinical guidance based on the Lee et al. 1999 derivation and validation study.
Formula
Worked example
A 68-year-old patient scheduled for elective colectomy (intraperitoneal - high-risk surgery) with a history of prior MI (ischemic heart disease) and creatinine of 2.3 mg/dL (elevated creatinine): RCRI = 3. This places the patient in Class IV with an estimated 30-day MACE rate of approximately 11%, warranting comprehensive cardiac evaluation before proceeding.
What is the RCRI?
The Revised Cardiac Risk Index (RCRI) is a validated, six-factor scoring system used by clinicians to estimate a patient's risk of major adverse cardiac events (MACE) before elective noncardiac surgery. Developed by Lee et al. and published in Circulation in 1999, the RCRI was derived from a cohort of 4,315 patients aged 50 or older undergoing major noncardiac surgery. It remains one of the most widely used and endorsed preoperative cardiac risk tools, appearing in the 2014 and 2024 AHA/ACC perioperative cardiovascular evaluation guidelines. MACE in the original study included myocardial infarction, pulmonary edema, ventricular fibrillation, primary cardiac arrest, and complete heart block occurring within 30 days of surgery. Each of the six risk factors contributes one point, giving a total score between 0 and 6. Higher scores correspond to higher absolute risk, with the transition from low to significant risk occurring at a score of 2 or more.
The Six RCRI Risk Factors Explained
Each factor was selected by Lee et al. as an independent predictor of perioperative MACE, controlling for other variables in a multivariate analysis. High-risk surgery covers intraperitoneal, intrathoracic, and suprainguinal vascular procedures - the types most physiologically stressful to the cardiovascular system. Superficial, orthopaedic (below the groin), or endoscopic procedures are generally not counted as high-risk for RCRI purposes. Ischemic heart disease is defined broadly: a prior myocardial infarction, a positive exercise stress test, current ischemic-type chest pain, the use of nitrates, or pathological Q waves on ECG all qualify. The patient does not need a recent MI; a remote history meets the criterion. Congestive heart failure includes documented prior heart failure, pulmonary edema, bilateral rales at rest, an audible S3 gallop, or chest X-ray findings consistent with elevated filling pressures. Preserved-ejection-fraction heart failure qualifies if the historical diagnosis is documented. Cerebrovascular disease means a prior stroke or transient ischemic attack (TIA). Asymptomatic carotid stenosis found incidentally does not qualify on its own. Insulin-dependent diabetes is the only diabetic category that counts. Patients managed with oral agents or diet alone do not meet this criterion, reflecting the greater autonomic and microvascular burden of insulin-requiring disease. Elevated creatinine uses a threshold of more than 2.0 mg/dL (177 µmol/L) measured before surgery. This threshold identifies patients with significant chronic kidney disease, which amplifies cardiovascular risk through volume overload, anemia, and uremic effects on the myocardium.
How to Interpret and Act on the RCRI Score
RCRI 0 (Class I, approximately 0.4% MACE): The 2024 AHA/ACC guideline supports proceeding directly to surgery in these patients. The absolute cardiac risk is similar to many routine non-surgical medical interventions. RCRI 1 (Class II, approximately 0.9% MACE): Still low overall. Most guidelines recommend proceeding to surgery while ensuring the patient has adequate functional capacity (at least 4 metabolic equivalents, or METs). If functional capacity is unknown or poor, a risk-benefit discussion is appropriate. RCRI 2 (Class III, approximately 6.6% MACE): This is the threshold where additional evaluation is most commonly triggered. Consider measuring BNP or NT-proBNP, assessing functional capacity with structured questioning, and selectively pursuing non-invasive stress testing only if results would change management. The absolute jump from 0.9% to 6.6% between scores of 1 and 2 is one of the most clinically important inflection points in the index. RCRI 3 or more (Class IV, approximately 11% or higher): These patients carry substantial perioperative cardiac risk. Cardiology consultation, optimisation of chronic cardiac medications (especially beta-blockers and statins), troponin monitoring in the perioperative period, and enhanced post-operative surveillance are all supported by guideline evidence. Whether surgery proceeds, is delayed, or is replaced by a less invasive alternative requires shared decision-making. Important caveat: the RCRI was derived in an era before high-sensitivity troponin testing. Contemporary studies using hs-troponin as the endpoint consistently find higher event rates than those in the Lee 1999 cohort, meaning RCRI may underestimate absolute risk in settings using sensitive biomarker monitoring.
RCRI in Clinical Context: Strengths and Limitations
The RCRI's main strengths are its simplicity, reproducibility, and robust external validation across hundreds of thousands of patients in meta-analyses. It requires only information already available from the standard preoperative history and basic laboratory work, and its discrimination is adequate (area under the ROC curve approximately 0.75) for a tool that uses only binary yes/no criteria. Key limitations: the index was derived in a single tertiary-care academic centre and may not generalise perfectly to community hospitals or populations with very different baseline comorbidity profiles. Its discrimination is lower for vascular surgery patients (AUC approximately 0.64), where specialised vascular risk scores may perform better. The RCRI does not capture functional capacity, which is an independent predictor of outcome. It does not adjust for urgency of surgery - emergent cases carry higher risk than what the score predicts for elective procedures. The RCRI should be used as one component of a broader preoperative evaluation, not as a sole gating criterion. The 2024 AHA/ACC guideline pairs RCRI with biomarker testing and functional capacity assessment to produce a more complete perioperative cardiac risk profile.
RCRI Score: Risk Classes and Estimated 30-Day MACE Rates
| RCRI Score | Risk Class | Risk Category | Estimated 30-Day MACE | Recommended Action |
|---|---|---|---|---|
| 0 | Class I | Very Low | 0.4% | Proceed to surgery; no additional cardiac testing needed |
| 1 | Class II | Low | 0.9% | Proceed; assess functional capacity if uncertain |
| 2 | Class III | Intermediate | 6.6% | Consider biomarkers, functional assessment, or stress testing |
| 3-6 | Class IV | High | ~11% | Cardiology consultation; optimise therapy; troponin monitoring |
Based on Lee et al. 1999 validation cohort (n=1,422). MACE = myocardial infarction, pulmonary edema, ventricular fibrillation, primary cardiac arrest, or complete heart block.
Frequently asked questions
What does an RCRI score of 2 mean?
An RCRI score of 2 places a patient in Class III (Intermediate Risk) with an estimated 30-day major adverse cardiac event (MACE) rate of approximately 6.6% based on the Lee et al. 1999 validation cohort. This is the key inflection point in the index - the risk jumps from about 0.9% at a score of 1 to 6.6% at a score of 2. Current guidelines generally recommend considering biomarker testing and functional capacity assessment before proceeding to elective surgery at this level.
Does insulin-dependent diabetes count differently from type 2 diabetes?
Yes. The original Lee et al. criterion is specifically pre-operative insulin use, not diabetes mellitus in general. Patients managing their diabetes with oral agents (metformin, SGLT2 inhibitors, etc.) or diet alone do not receive a point for this factor. Only patients who use insulin before surgery meet the criterion. This reflects the greater autonomic neuropathy, microvascular disease, and overall cardiovascular burden associated with insulin-requiring disease.
Is a laparoscopic abdominal procedure considered high-risk surgery for RCRI?
The original Lee criterion for high-risk surgery was intraperitoneal, intrathoracic, or suprainguinal vascular procedures. Intraperitoneal includes laparoscopic procedures as well as open ones. However, clinical practice and some updated interpretations distinguish between major open abdominal resections and short-duration laparoscopic operations. When in doubt, the safest approach is to apply the original intraperitoneal criterion and count it as high-risk, particularly for colectomies, gastrectomies, or liver/pancreas procedures regardless of approach.
Can the RCRI be used for emergency surgery?
The RCRI was derived and validated in patients undergoing elective noncardiac surgery, so its calibration is best in that context. Emergency surgery carries additional risk beyond what the score captures - specifically the physiological stress of urgency, potential haemodynamic instability, and the inability to optimise medical therapy before the procedure. Many guidelines note that emergency surgery generally proceeds regardless of RCRI, with risk-reduction focused on intra- and post-operative monitoring rather than pre-operative testing that would delay the procedure.
How does RCRI compare to other preoperative cardiac risk tools?
The RCRI is the most widely validated and guideline-endorsed general preoperative cardiac risk tool. The American College of Surgeons NSQIP Surgical Risk Calculator offers more granular procedural data. The Vascular Quality Initiative Cardiac Risk Index may outperform RCRI specifically for vascular surgery patients. The RCRI remains the starting point recommended by both the AHA/ACC and European Society of Cardiology perioperative guidelines, with other tools used to refine estimates in specific subgroups.
Should I order a stress test if the RCRI is 3 or more?
Not automatically. The 2024 AHA/ACC perioperative guideline recommends non-invasive stress testing only when functional capacity is unknown or poor AND the results would change clinical management - specifically, whether surgery would be cancelled, delayed for coronary revascularisation, or changed to a less invasive procedure. For patients where surgery will proceed regardless, routine stress testing has not been shown to improve outcomes. Cardiology consultation is often the most appropriate first step at RCRI 3 or more, rather than ordering tests independently.
Sources
- Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100(10):1043-1049.
- 2024 AHA/ACC/AACVPR/AATS/ABC/ACEP/ACS/ASNC/ASPC/HOAMP/HRS/SCAI/SCCT/SCMR/STS Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. Journal of the American College of Cardiology. 2024.
- Duceppe E, Parlow J, MacDonald P, et al. Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery. Can J Cardiol. 2017;33(1):17-32.